- Drug Name: Entyvio
- Generic Name: vedolizumab
- Dosage Forms and Strengths: For injection: 300 mg vedolizumab in a single-dose vial.
- Manufactured by: Takeda Pharmaceuticals U.S.A., Inc
An integrin receptor antagonist called ENTYVIO is prescribed to
- adults for the management of moderately to highly active ulcerative colitis.
- Crohn’s disease that is moderately to severely active.
- Take ENTYVIO as your doctor prescribes it. For adults with ulcerative colitis (UC) or Crohn’s disease (CD), the typical dosage is 300 mg. Your doctor will administer this through an IV infusion over about 30 minutes. You’ll receive it at zero, two, and six weeks, then every eight weeks afterward.
- If you don’t feel better after 14 weeks of treatment, your doctor may stop giving you ENTYVIO.
- Before using ENTYVIO, it’s mixed with special liquids like Sterile Water for Injection or Sodium Chloride Injection. It’s diluted further with Sodium Chloride Injection or Lactated Ringer’s Injection before it’s given to you. Your doctor will have detailed instructions on how to prepare and store it.
- Make sure you’re up to date with all your vaccines before starting ENTYVIO. This helps keep you protected according to current immunization guidelines. Always follow your doctor’s advice and ask any questions you have about your treatment.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.